EP 4125854 A1 20230208 - COMPOSITIONS COMPRISING 15-HEPE FOR TREATING OR PREVENTING HEMATOLOGIC DISORDERS, AND/OR RELATED DISEASES
Title (en)
COMPOSITIONS COMPRISING 15-HEPE FOR TREATING OR PREVENTING HEMATOLOGIC DISORDERS, AND/OR RELATED DISEASES
Title (de)
ZUSAMMENSETZUNGEN MIT 15-HEPE ZUR BEHANDLUNG ODER PRÄVENTION HÄMATOLOGISCHER ERKRANKUNGEN UND/ODER VERWANDTER ERKRANKUNGEN
Title (fr)
COMPOSITIONS COMPRENANT 15-HEPE POUR LE TRAITEMENT OU LA PRÉVENTION DE TROUBLES HÉMATOLOGIQUES, ET/OU DE MALADIES ASSOCIÉES
Publication
Application
Priority
EP 2020059682 W 20200403
Abstract (en)
[origin: WO2021197639A1] The present disclosure relates to methods of treating or preventing hematologic disorders by administration of 15-HEPE or compositions thereof.
IPC 8 full level
A61K 31/202 (2006.01); A61P 7/00 (2006.01); A61P 7/02 (2006.01); A61P 7/06 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01)
CPC (source: EP IL KR)
A61K 31/202 (2013.01 - EP IL KR); A61P 7/00 (2017.12 - EP IL KR); A61P 7/02 (2017.12 - EP IL KR); A61P 7/06 (2017.12 - EP IL KR); A61P 35/00 (2017.12 - EP IL KR); A61P 35/02 (2017.12 - EP IL KR)
Citation (search report)
See references of WO 2021197639A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021197639 A1 20211007; AU 2020440809 A1 20221110; BR 112022020012 A2 20221213; CA 3179158 A1 20211007; CN 115715192 A 20230224; EP 4125854 A1 20230208; IL 297114 A 20221201; JP 2023528562 A 20230705; KR 20220163468 A 20221209; MX 2022012404 A 20230209
DOCDB simple family (application)
EP 2020059682 W 20200403; AU 2020440809 A 20200403; BR 112022020012 A 20200403; CA 3179158 A 20200403; CN 202080101694 A 20200403; EP 20717175 A 20200403; IL 29711422 A 20221006; JP 2022560042 A 20200403; KR 20227038593 A 20200403; MX 2022012404 A 20200403